Operating as a wholesale pharmaceutical distributor involves thousands of stock keeping units, strict batch numbers, and a constant flow of near-expiry or broken medicine stock. When retailers send back expired drugs, distributors must reconcile those returns against manufacturer credit notes appearing in GSTR-2B.
A standard general reconciliation guide such as our GSTR-2B reconciliation and ITC matching guide covers invoice matching, but pharmaceutical distribution introduces specific statutory rules for expired stock adjustments.
The two mechanisms under Circular 72/46/2018-GST
Handling time-expired drugs requires following the procedure laid down by the Central Board of Indirect Taxes and Customs. As clarified in CBIC Circular No. 72/46/2018-GST para 3(A) and 3(B), businesses in the pharmaceutical supply chain have two legal options to account for expired goods:
- Fresh supply with tax invoice (Para 3(A)): The person returning the time-expired goods (such as a retailer returning stock to the distributor, or the distributor returning stock to the manufacturer) issues a regular tax invoice. The recipient can claim input tax credit on this supply subject to the conditions of Section 16 of the CGST Act. If the manufacturer subsequently destroys these time-expired medicines, the manufacturer must reverse the input tax credit availed on that return supply under Section 17(5)(h) of the CGST Act.
- Credit note option (Para 3(B)): The supplier who originally sold the goods issues a credit note under Section 34(1) of the CGST Act. The supplier can adjust their output tax liability provided the credit note is issued within the statutory deadline set out in Section 34(2), and provided the recipient reverses the corresponding input tax credit.
Common mistake: Missing the timeline under Section 34(2) of the CGST Act. A manufacturer can issue a GST credit note to reduce output tax liability only up to 30 November following the end of the financial year in which the original supply was made, or the date of filing the annual return, whichever is earlier. If issued after this deadline, the credit note can only be a commercial credit note without tax adjustment.
How manufacturer credit notes affect GSTR-2B reconciliation
When a pharmaceutical manufacturer issues a GST credit note for expired stock or breakage, they upload it in Form GSTR-1. According to GST portal guidelines in the GSTN GSTR-1 user tutorial, credit and debit notes declared in Table 9B auto-populate directly into the distributor's Form GSTR-2B.
In your GSTR-2B, credit notes appear as negative values in Part A. These entries automatically reduce your net ITC available in Table 4(A) of Form GSTR-3B. If your ERP accounting software records the credit note in a different month than when the manufacturer files it, your purchase register will disagree with GSTR-2B.
Worked example: batch return and credit note calculation
Consider M/s Apex Pharma Distributors, who received expired antibiotic strips from retail chemists and returned them to the manufacturer, Alpha Life Sciences. The original supply occurred at an 18% GST rate.
Alpha Life Sciences accepted the expired batch and issued a credit note with the following details:
| Document | Batch Ref | Taxable Value | CGST (9%) | SGST (9%) | Total Value | GSTR-2B Impact |
|---|---|---|---|---|---|---|
| CN-2026-081 | AMX-402 | ₹1,00,000 | ₹9,000 | ₹9,000 | ₹1,18,000 | Reduces ITC by ₹18,000 |
| CN-2026-082 | CIP-109 | ₹50,000 | ₹4,500 | ₹4,500 | ₹59,000 | Reduces ITC by ₹9,000 |
| Total | 2 Batches | ₹1,50,000 | ₹13,500 | ₹13,500 | ₹1,77,000 | Total ITC reduction: ₹27,000 |
Calculation check:
Total taxable value = ₹1,00,000 + ₹50,000 = ₹1,50,000.
CGST at 9% = ₹1,50,000 × 0.09 = ₹13,500.
SGST at 9% = ₹1,50,000 × 0.09 = ₹13,500.
Total tax reversal = ₹13,500 + ₹13,500 = ₹27,000.
If Apex Pharma Distributors fails to account for CN-2026-081 and CN-2026-082 in their books during the return period, their purchase register will show ₹27,000 more eligible ITC than Form GSTR-2B permits, triggering automated portal mismatch notices under Rule 88D.
Common reconciliation bottlenecks for pharma wholesalers
Pharmaceutical distribution businesses face three typical reconciliation hurdles every month:
- Rate differences on old stock: Medicines sold eighteen months ago may have had a rate change or price revision. Ensure credit notes reference the actual tax rate on the original invoice.
- Partial batch acceptance: Manufacturers often discard vials damaged in transit and reject credit for them. If the manufacturer issues a credit note for less than your debit memo, the difference must be adjusted in your inventory expense account.
- Timing delays in GSTR-1 filing: If a manufacturer delays filing GSTR-1, the credit note will not show in your current GSTR-2B. Reversing ITC prematurely or failing to track pending manufacturer filings creates accounting variance.
Frequently asked questions
How should a pharma distributor handle expiry goods returned by chemists?
Under CBIC Circular No. 72/46/2018-GST, expiry returns can follow two routes. The chemist can issue a fresh tax invoice treating the return as a fresh supply, or the distributor can issue a credit note under Section 34(1) of the CGST Act.
Does a pharma distributor need to reverse ITC when a manufacturer issues a credit note?
Yes. When the manufacturer reports a financial or GST credit note under Section 34(1) in GSTR-1, it reflects in the distributor's GSTR-2B. Under Section 34(2), the distributor must reduce their input tax credit in Form GSTR-3B.
What happens if time-expired drugs are destroyed by the manufacturer?
If time-expired goods are returned as a fresh supply and later destroyed by the manufacturer, the manufacturer must reverse the ITC availed on that return supply under Section 17(5)(h) of the CGST Act as clarified in Circular No. 72/46/2018-GST.
Reconcile your pharma distributor purchase registers
Compare thousands of manufacturer invoices, credit notes, and batch records against your official GSTR-2B in seconds. Your GSTR-2B and purchase register files are read in your browser and never uploaded to any server.
Last checked: 26 October 2026. Sources: CGST Act Section 34, CBIC Circular No. 72/46/2018-GST, GSTN GSTR-1 Tutorial.